KFA115
CKFA115A12101
Phase 1 small_molecule active
Quick answer
KFA115 for Carcinoma, Non-Small-Cell Lung is a Phase 1 program (small_molecule) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Carcinoma, Non-Small-Cell Lung
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active